ORIGINAL
Shinta Yamamoto, Hiroshi Okada, Natsuko Shinagawa, Nozomi Kuramoto, Yuriko Ono, Megumi Minamida, Junya Hironaka, Chihiro Munekawa, Yuka Hasegawa, Hanako Nakajima, Nobuko Kitagawa, Takuro Okamura, Yoshitaka Hashimoto, Takafumi Osaka, Noriyuki Kitagawa, Rieko Nakatani, Saori Majima, Takafumi Senmaru, Emi Ushigome, Naoko Nakanishi, Masahide Hamaguchi, Michiaki Fukui
April 17, 2025
Recommendation from the Editor in Chief
Exactly the insightful story of incretin hormone, glucose-dependent insulinotropic hormone (GIP) has long attracted broad attention among basic and clinical fields of endocrinology. A series of drugs co-stimulating multiple gut hormone receptors are now applied in clinics of type 2 diabetes, obesity disease and relevant metabolic diseases. In this issue, Professor Emeritus of Kyoto University, Dr. Nobuya Inagaki and his colleague, world-renowned pioneering scientists of GIP research, contribute a sophisticated and cutting-edge review on update of physiology and clinical applications of GIP. Our editorial team has a firm belief that all readers will definitely be fascinated and moved by the full of academic incense contained.